Pancreatic cancer AI screening is the new highlight of preventive care — from workflow integration to radiology collaboration, live in 4 weeks.
Pancreatic cancer has one of the lowest survival rates — and almost no early symptoms. Your clients need it; nobody offers it yet.
Pancreatic cancer ranks among Taiwan's top-10 cancer killers; the high-risk population (60+, family history, diabetes, smoking) keeps growing.
Beyond routine heart-lung checkups, AI pancreatic screening makes your center the place that “sees earlier.”
TFDA license No. 007946, FDA Breakthrough, AUC 0.95 — regulatory and literature-backed, ready to convince.
A dedicated project manager throughout; radiologist and technologist training included.
Review equipment (CT model, PACS version) and workflow; define report format and alert rules.
AI server setup and PACS/RIS interfacing; automatic DICOM routing; zero extra steps for radiology.
Validation on institutional data plus training for radiologists and technologists (online course included).
Go-live, pilot run, performance dashboard delivered. Monthly quality reports thereafter.
PANCREASaver® doesn't change how radiologists read — it simply adds a pair of eyes that never tire.
CT scan finishes; images are analyzed by AI in the background (~60–90 seconds).
Suspicious findings are flagged side-by-side with the original images for the radiologist's review.
For positive cases, the system suggests follow-up — no early signal slips through.
Leave your contact and our team will reach out within two business days.
Request the program